Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of diffusion-weighted MRI in biological image-guided radiation therapy: a roadmap.

Physics in medicine and biology·2026
Same author

Cancer-selective photoimmunotherapy spares T cells and NK cells and promotes antitumor immunity in an allogeneic human 3D culture model.

Photochemistry and photobiology·2026
Same author

Gompertz growth with a shared carrying capacity optimally simulates primary and metastatic tumor growth dynamics.

British journal of cancer·2026
Same author

75 Years of Mathematical Oncology.

bioRxiv : the preprint server for biology·2026
Same author

Speaking Mathematical Models into Existence.

Cancer research·2025
Same author

Investigating the Limits of Predictability of Magnetic Resonance Imaging-Based Mathematical Models of Tumor Growth.

Cancers·2025
Same journal

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

JCO clinical cancer informatics·2026
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
Same journal

Foundation Model-Driven Regions of Interest Classification and Renaming in Cancer Radiotherapy: A Customizable, Retraining-Free Workflow Across Institutions.

JCO clinical cancer informatics·2026
Same journal

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

Simulating Cancer Recurrence Patterns From Post-Treatment Viable Tumor Burden Distributions.

Mohammad U Zahid1, Joseph D Butner1, David M Swanson2

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

JCO Clinical Cancer Informatics
|May 8, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a mathematical model linking tumor growth dynamics to recurrence patterns. The model simulates tumor regrowth and recurrence, aiding in the interpretation of clinical trial outcomes and the redesign of future trials for improved success.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Experiment Videos

Last Updated: May 10, 2026

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Area of Science:

  • Mathematical Oncology
  • Tumor Growth Dynamics
  • Clinical Trial Modeling

Background:

  • Ordinary differential equation models accurately describe tumor growth and treatment response.
  • Extending continuous models to simulate population-level outcomes is crucial for understanding recurrence patterns.

Purpose of the Study:

  • To develop a novel mathematical model for simulating tumor regrowth and population-level recurrence patterns.
  • To conceptualize post-treatment viable tumor burden distributions within a treatment population.
  • To connect tumor dynamics models with recurrence patterns for improved clinical trial interpretation.

Main Methods:

  • Utilized a mathematical model of tumor regrowth dynamics incorporating a minimum viable tumor burden threshold for cure.
  • Simulated tumor regrowth until the tumor burden exceeded a detection threshold to model Kaplan-Meier curves.
  • Qualitatively fitted the model to real-world recurrence data from a head and neck cancer clinical trial (RTOG 9003).

Main Results:

  • Explored the impact of model parameters and growth laws on simulated Kaplan-Meier curve shapes.
  • Demonstrated the model's utility in understanding clinical trial results.
  • Presented qualitative fitting of the model to clinical recurrence data.

Conclusions:

  • The theoretical framework connects tumor dynamics models to recurrence patterns.
  • Provides a new methodology for interpreting Kaplan-Meier curves.
  • Offers insights into clinical trial failures and guidance for redesigning future trials for success.